USF Health Trials $42 At-Home Glaucoma Screening Device for Early Detection

USF Health is testing a $42 at-home glaucoma screening tool aimed at helping patients catch the disease earlier.

At just $42, a new at-home screening device could put glaucoma detection within reach of millions who currently lack access to regular eye exams. USF Health researchers are testing the technology, which is designed to let patients monitor their own vision and identify warning signs before significant damage occurs. Doctors involved in the trial say the goal is to prompt earlier care-seeking among patients who might otherwise miss routine screenings. Glaucoma, a leading cause of irreversible blindness, often progresses without noticeable symptoms until vision loss is advanced, making early detection critical.

Why it matters

Glaucoma affects an estimated 80 million people worldwide and frequently goes undiagnosed until permanent damage is done. An affordable at-home screening option could significantly expand early detection, particularly for patients with limited access to eye care specialists.

What's next

Results from USF Health's trial will determine whether the device is effective enough to recommend for broader patient use.

Key facts

• The at-home glaucoma screening device costs $42
• USF Health is conducting the clinical testing of the technology
• The tool is designed for patients to self-monitor their vision at home
• Doctors say the device is intended to prompt earlier care-seeking
• Glaucoma is a leading cause of irreversible blindness and often shows no early symptoms

Bias & framing notes

Both sources appear to run identical reporting — likely the same wire copy or press release — offering no independent corroboration or additional detail. No clinical data, trial size, or device name is provided, limiting the depth of verification.

NewsClear — neutral news & congressional tracking · Bill of the Week